These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14858438)

  • 21. Inhibition of antithrombin by protein SV-IV normalizes the coagulation of hemophilic blood.
    Di Micco B; Caen J; Colonna G; Macalello MA; Marchese M; Stiuso P; Di Micco P; Morelli F; Metafora S
    Eur J Pharmacol; 2000 Mar; 391(1-2):1-9. PubMed ID: 10720629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of heparins on thrombin generation in hemophilic plasma supplemented with FVIII, FVIIa, or FEIBA.
    Parmar N; Berry LR; Paredes N; Chan AK
    Clin Lab; 2005; 51(3-4):157-66. PubMed ID: 15819171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihemophilic factor (AHF): plasma levels after administration of AHF preparations to hemophilic dogs.
    WAGNER RH; LANGDELL RD; RICHARDSON BA; FARRELL RA; BRINKHOUS KM
    Proc Soc Exp Biol Med; 1957 Oct; 96(1):152-5. PubMed ID: 13485042
    [No Abstract]   [Full Text] [Related]  

  • 24. Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma.
    Dai L; Bevan D; Rangarajan S; Sørensen B; Mitchell M
    Haemophilia; 2011 Sep; 17(5):e944-8. PubMed ID: 21371192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Coagulating factors in erythrocytes. II. Activity of hemolysates and their derivatives on hemophilic plasma with platelets removed or in the presence of platelets and on normal plasma with platelets removed].
    TROPEANO L; CACCIOLA E; FERRAUTO A
    Boll Soc Ital Biol Sper; 1958 Oct; 34(19):1176-9. PubMed ID: 13607709
    [No Abstract]   [Full Text] [Related]  

  • 26. [Coagulating factors in erythrocytes. III. Activity of a precipitable factor in the hemolysate on hemophilic plasma with platelets removed or in the presence of platelets and on normal plasma with platelets removed].
    TROPEANO L; CACCIOLA E; FERRAUTO A
    Boll Soc Ital Biol Sper; 1958 Oct; 34(19):1179-84. PubMed ID: 13607710
    [No Abstract]   [Full Text] [Related]  

  • 27. Human prothrombin metabolism in normal man and in hypocoagulable subjects.
    Shapiro SS; Martinez J
    J Clin Invest; 1969 Jul; 48(7):1292-8. PubMed ID: 5794251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on blood coagulation. I. The influence of AHG concentrate on the activity of antithrombin 3 in normal and hemophilic serum.
    Gang NF; Denstedt OF
    Mt Sinai J Med; 1972; 39(4):352-6. PubMed ID: 4538013
    [No Abstract]   [Full Text] [Related]  

  • 29. [A modification of a method of evaluating the coagulation activity of factor VIII].
    Levchenko LB; Papaian LP; Kotovshchikova MA; Khrolova PV
    Lab Delo; 1989; (5):22-5. PubMed ID: 2473253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma.
    Nordfang O; Valentin S; Beck TC; Hedner U
    Thromb Haemost; 1991 Oct; 66(4):464-7. PubMed ID: 1796397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ANTIBODY TO ANTIHEMOPHILIC FACTOR AND ITS LACK OF REACTION WITH HEMOPHILIC PLASMA.
    MCLESTER WD; WAGNER RH
    Am J Physiol; 1965 Mar; 208():499-507. PubMed ID: 14264741
    [No Abstract]   [Full Text] [Related]  

  • 32. Thromboplastin in the urine of normal and hemophilic men.
    TOCANTINS LM; LINDQUIST JN
    Fed Proc; 1947; 6(1 Pt 2):215. PubMed ID: 20342895
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on a proteolytic enzyme in human plasma; the relationship between the proteolytic activity of plasma and blood coagulation.
    RATNOFF OD; HARTMANN RC; CONLEY CL
    J Exp Med; 1950 Feb; 91(2):123-33. PubMed ID: 15404220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PHYSIOLOGY AND PATHOLOGY OF BLOOD COAGULATION. A REVIEW OF THE LITERATURE OF 1963. I.
    KOLLER F; LAEUBLI B; VOGEL-MENG J
    Thromb Diath Haemorrh; 1964 Jan; 10():502-74. PubMed ID: 14113386
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hemophilic syndromes; Aggeler's method of preparing plasma and serum fractions containing antihemophilic globulin and the plasma thromboplastin component].
    MARCACCI M
    Riv Ist Sieroter Ital; 1954; 29(1):104-14. PubMed ID: 13168124
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on blood coagulation. II. Kinetic study of the interaction between antihemophilic globulin and antithrombin 3 in normal and hemophilic sera.
    Gang NF; Denstedt OF
    Mt Sinai J Med; 1972; 39(5):429-34. PubMed ID: 4538758
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the incomplete correction of the hemophilic hemocoagulative error on the part of conductor blood. Thromboelastographic observations].
    GIACCA S; NEGRINI AC
    Arch Maragliano Patol Clin; 1959 Aug; 15():1071-80. PubMed ID: 13827794
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-hemophilic globulin levels in carriers of hemophilia A.
    RAPAPORT SI; PATCH MJ; MOORE FJ
    J Clin Invest; 1960 Nov; 39(11):1619-25. PubMed ID: 13739554
    [No Abstract]   [Full Text] [Related]  

  • 39. Thromboelastography in children with coagulation factor deficiencies.
    Chitlur M; Warrier I; Rajpurkar M; Hollon W; Llanto L; Wiseman C; Lusher JM
    Br J Haematol; 2008 Jun; 142(2):250-6. PubMed ID: 18492116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clotting of hemophilic blood with purified platelet cofactor I, platelet factor 3 and threone.
    SEEGERS WH; LANDABURU RH; HOLBURN RR; TOCANTINS LM
    Proc Soc Exp Biol Med; 1957 Jul; 95(3):583-5. PubMed ID: 13453515
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.